Recap: Enact Holdings Q4 Earnings

Enact Holdings (NASDAQ:ACT) reported its Q4 earnings results on Tuesday, February 6, 2024 at 04:20 PM. Here’s what…

Enact Holdings (NASDAQ:ACT) reported its Q4 earnings results on Tuesday, February 6, 2024 at 04:20 PM.

Here’s what investors need to know about the announcement.

Earnings

Enact Holdings beat estimated earnings by 6.52%, reporting an EPS of $0.98 versus an estimate of $0.92.

Revenue was up $19.35 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.14 which was followed by a 0.87% increase in the share price the next day.

Here’s a look at Enact Holdings’s past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate 0.88 0.82 0.80 0.84
EPS Actual 1.02 1.10 1.08 0.90
Revenue Estimate 291.37M 285.54M 272.28M 277.25M
Revenue Actual 299.04M 277.52M 280.94M 276.84M

To track all earnings releases for Enact Holdings visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Pervasip Reports Slight YoY Decrease In Q1 Revenue As It Prepares For Cannabis Spin-Off

Pervasip announced on Tuesday its 2024 first-quarter financial results. Simultaneously, the Seattle, Washington-based company said it's still in the restructuring process and preparation for the spin-out of all of its cannabis assets. "We are entering our final phase of restructuring which involves making difficult decisions to ensure additional expense reductions and separating the company from assets it has held for many years," German Burtscher, Pervasip's president and chief executive officer, said. Additionally, as part of the restructuring, George Jordan has resigned from his duties as CFO and COO of the company and will stay on as an advisor, supporting management through its final phase of changes in preparation for the spin-out of Artizen Corporation.

PVSP